Sheffield orthopaedic consultant’s research wins ‘Research Highlight of the Year’ at Arthritis UK awards

Professor Mark Wilkinson, a consultant orthopaedic surgeon at Sheffield’s Thornbury Hospital has received national recognition for the work he carried out with colleagues looking at the genetics of osteoarthritis.
‘Exploring the genetics of osteoarthritis’ was named Arthritis UK’s ‘Research Highlight of the Year.’ The winner, voted on by the public, will benefit from a £10k research grant provided by Thornbury Hospital’s owners Circle Health Group.
Professor Eleftheria Zeggini and team, which includes Professor Mark Wilkinson, focused their research on the genetics of osteoarthritis. It is the largest-ever osteoarthritis genetics study ever conducted and used genetic data from nearly 2 million people. Their research found over 950 genetic links to osteoarthritis, uncovering 8 different underlying disease processes.
Circle Health Group, Thornbury Hospital’s owner, is one of the UK’s leading private hospital operators and supports over 2 million patients each year to access everything from specialist medical advice and assessment to imaging and diagnostics, physiotherapy, health assessments, surgical and non-surgical treatment. Committed to providing its patients with the latest in technology and clinical innovation, the collaboration with Arthritis UK is yet another example of Circle Health Group working with strategic partners to improve the research, understanding and treatment of conditions like arthritis.

It is estimated that arthritis impacts close to 10 million people in the UK alone. The term is used to describe pain, swelling and stiffness in a joint or joints. There is no cure for arthritis, however, research grants like the one Circle Health Group have provided, are key to improving our understanding of the condition and developing new treatments, earlier diagnosis, and hopefully a cure.
Professor Eleftheria Zeggini and team hope their groundbreaking findings could help to understand osteoarthritis better, showing new drug targets and paving the way for better and more personalised treatments.
Commenting, Professor Mark Wilkinson, said:
"The GO team and collaborators are delighted that this work, bringing a substantial advance in our understanding to the field of osteoarthritis genomics, is recognised by this prestigious award. We hope that these discoveries will accelerate the path to novel treatments to alleviate the burden and suffering of this condition on patients worldwide"
Deborah Alsina MBE, chief executive of Arthritis UK, said:
“I am delighted to see ‘Exploring the genetics of osteoarthritis’ and the team behind the research win this competition and thank you to Circle Health Group for their valuable sponsorship to help make this campaign possible. It was a tough competition, and you can see a challenge for the public to choose a winner from the exceptionally high calibre of entries, all of which build on our ninety-year legacy of significant advancements in the understanding and treatment of arthritis.”